TO STUDY THE CLINICAL AND DEMOGRAPHIC PROFILE OF COVID-19 PEDIATRIC PATIENTS (UP TO 18 YEARS) IN A TERTIARY CARE CENTER OF JAIPUR, RAJASTHAN

Author:

AGARWAL SHEJALORCID,PARMAR SHALIN,MARWAH PRIYAORCID,KAKKAR MUNISH KUMAR,GUPTA JITENDRA KUMAR,ABHISHEK KUMAR SHARMA

Abstract

 Objective: Coronavirus disease-19 (COVID-19) infection has quickly developed into a global pandemic. According to the available evidence, children appear to be less likely to be afflicted and the condition may be less severe, but things could change. Rapid deterioration and enhancements in the physiologic state are a hallmark of the pediatric community. Therefore, this study was conducted with the aim to study the demographic and clinical parameters of pediatric COVID patients. Methods: This hospital-based prospective and retrospective study was conducted during April 1st, 2020–July 2022 at the COVID ward and outpatient department, Mahatma Gandhi Medical College and Hospital, Jaipur. We included 276 children up to 18 years suffering from COVID-19 infection. We collected data of our study population from medical records and filled up the predesigned pro forma for admitted patients. Admitted children were classified as, per ICMR guidelines as: asymptomatic, mild, moderate, and severe variety. Statistical analysis was done with the SPSS software. Results: Highest percentage of cases 48.39% in the age group 12–18 years, were followed by 31.45% in the 7–12-year-old age group. About 13.04% of patients were asymptomatic, whereas the remaining cases were symptomatic, with severity levels of mild 49.28%, moderate 26.81%, and severe 10.87%. Fever was the most prevalent symptom 69.2%, cough at 43.84%, throat ache 18.12%, breathing difficulties 15.22%, headache 2.54%. Conclusion: In the present study, we concluded that during the third wave of the pandemic, most children had symptomatic illnesses, but recovery was fast among non-hospitalized children. Multisystem inflammatory syndrome in children was more common in elderly children.

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference13 articles.

1. E. Terpos, I. Ntanasis-Stathopoulos, I. Elalamy, E. Kastritis, T.N. Sergentanis, M. Politou, et al., Hematological findings and complications of COVID-19, Am. J. Hematol. 2020;95 (7):834–847.

2. Hui D.S. An overview on severe acute respiratory syndrome (SARS) Monaldi Arch. Chest Dis. 2005;63(3):149–157.

3. Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel corona virus infection: clinical and epidemiological features. Clin Infect Dis. 2020.

4. Lifen Y, Zhenyuan D, Mengqi D, et al. Suggestions for medical staff from department of pediatrics during the treatment of 2019nCoV infection/pneumonia. J N Med (Pre Print). 2020.

5. Hu T, Fang L, Junling W, et al. Clinical characteristics of 2019 novel corona virus (2019‐nCoV) infection in children and family prevention and control. Med J Wuhan Univ (Pre Print). 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3